Eiger BioPharmaceuticals, Inc., along with its four affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Northern District of Texas on April 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 USD | +7.00% | +8.33% | -61.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.40% | 3.85M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Eiger BioPharmaceuticals, Inc. Filed for Bankruptcy